|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, marketing, and distribution | |||||
| General and administrative | |||||
| Gain on sale/disposition of assets, net | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other expense, net: | |||||
| Other income/(expense), net | |||||
| Interest expense, net | |||||
| Total other (expense)/income, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic - net income | |||||
| Diluted - net income | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...